Serial 97516511
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Oct 2025)
What this means for you
This application is over — abandoned 07 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97516511
- Mark type
- Design / logo
- Filed
- 22 Jul 2022
- Published for opposition
- 16 May 2023
- Abandoned
- 07 Oct 2025
- Attorney of record
- Jared M. Barrett
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of liver disease and monogenic disease; pharmaceutical preparations for the treatment of metabolic disorders, or central nervous system disorders; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Alport Syndrome; pharmaceutical preparations for the treatment of glomerulonephropathy; pharmaceutical preparations for the treatment of glomerulonephritis
Owner
- Travere Therapeutics, Inc., San Diego, CA, US
- Travere Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 07 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2024 — SOU EXTENSION 2 GRANTED
- 09 Jul 2024 — SOU EXTENSION 2 FILED
- 09 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Aug 2023 — CORRECTED NOA E-MAILED
- 10 Aug 2023 — SOU EXTENSION 1 GRANTED
- 26 Jul 2023 — SOU EXTENSION 1 FILED
- 10 Aug 2023 — DIVISIONAL PROCESSING COMPLETE
- 26 Jul 2023 — DIVISIONAL REQUEST RECEIVED
- 09 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Jul 2023 — TEAS REQUEST TO DIVIDE RECEIVED
- 26 Jul 2023 — SOU TEAS EXTENSION RECEIVED